Navigation Links
IADR and GlaxoSmithKline Consumer Healthcare announce winners of 2009 Innovation in Oral Care Awards
Date:3/17/2009

Alexandria, Va. The International Association for Dental Research (IADR) and GlaxoSmithKline (GSK) Consumer Healthcare today announced the 2009 winners of the annual IADR/GSK Innovation in Oral Care Awards. The three prestigious awards recognize research in innovative oral care technologies that may maintain and improve oral health and the quality of life.

In its sixth year of award support, GSK Consumer Healthcare has contributed nearly $1.4 million. Each of the three 2009 winners will receive a $75,000 unrestricted research grant, which is funded by GSK Consumer Healthcare and administered by IADR. The 2009 winners are:

  • Eric Reynolds, B.Sc., Ph.D., The University of Melbourne School of Dental Science, Australia, for "Development of Oxantel to Prevent Periodontopathogenic Biofilm Formation." Oxantel is already approved for use in humans at relatively high concentrations as a treatment for intestinal parasites. Reynolds and his team have patented its use for the treatment of periodontal diseases. Once the efficacy of Oxantel against periodontopathogenic bacterial biofilms has been demonstrated, it should be possible to develop a professional product that will result in improved oral health for persons with periodontitis.

  • Rena D'Souza, B.D.S., M.S., D.D.S., Ph.D., Baylor College of Dentistry, Texas A&M Health Science Center in Dallas, USA, for "Nanostructured Peptide Hydrogels and Stem Cells for Dentin-Pulp Complex Regeneration." This innovative research will develop and test novel peptide-based hydrogels as scaffolds to promote the differentiation of adult stem cells and the formation of dentin and pulp tissues. This biologically based endodontic therapy offers an important alternative for individuals in a clinical situation with an otherwise poor prognosis.

  • Sandra Bordin, Ph.D., The University of Washington School of Dentistry, Seattle, USA, for "Optical Coherence Tomography for Non-invasive Diagnosis of Periodontal Disorders." This proposal plans to develop miniature, high-resolution Optical Coherence Tomography (OCT) imaging needle devices to explore the validity of this bioengineering technology, which would have a near-term impact on oral health improvement by guiding biopsies and monitoring treatment response in a broad range of oral conditions, thus reducing costs of healthcare. In addition, this technology could stimulate the development/analysis of molecular studies aimed at augmenting the innate capacity of soft connective tissues to heal and regenerate.

This year, the IADR/GSK Innovation in Oral Care Awards received 28 applications from teams of researchers from around the globe. Each application was reviewed by a panel of experts under the chairmanship of Dr. Mariano Sanz, Dean, Universidad Complutense de Madrid (Spain) Dental School.

The awards will be presented during the 87th General Session & Exhibition of the IADR, to be held April 1-4, 2009, in Miami, Florida, USA.

"GSK is honored to partner with IADR to continue to offer the Innovation in Oral Care Awards to such talented investigators," said Dr. Stuart R. Smith, Vice President Global Dental Scientific and Professional Communications for GSK. "These teams have garnered ground-breaking research, and I'm confident that this research will produce innovative technologies that can be used to improve oral care."

"IADR is grateful for the tremendous contributions GSK has made to fund the prestigious Innovation in Oral Care Awards," said IADR President J.M. "Bob" ten Cate. "This awards program has received proposals from many superb investigators, and IADR is very pleased with the high aggregate standard of the applications submitted for improving oral health worldwide."


'/>"/>

Contact: Ingrid Thomas
IThomas@iadr.org
703-299-8084
International & American Association for Dental Research
Source:Eurekalert

Related medicine news :

1. GlaxoSmithKline Responds to JAMA Articles
2. MedImmune Licenses Reverse Genetics Technology to GlaxoSmithKline for Use in Influenza Vaccine Development and Production
3. Congressional Black Caucus Foundation and GlaxoSmithKline Announce Supplier Business Initiative Study Results
4. AUDIO from Medialink and GlaxoSmithKline: A New Nasal Spray for Allergy Relief
5. Mylan Announces Settlement of Paroxetine Hydrochloride Extended-Release Tablets with GlaxoSmithKline
6. GlaxoSmithKline Aids California Fire Relief Efforts
7. Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program
8. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
9. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
10. GlaxoSmithKline Presents Innovative Neuroscience Pipeline
11. GlaxoSmithKline Receives FDA Complete Response Letter for Cervical Cancer Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... 2016 , ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect ... videos a whole new perspective by using the title layers in ProSlice Levels ... , ProSlice Levels contains over 30 Different presets to choose from. FCPX ...
(Date:6/26/2016)... Birmingham, Lake Orion, Clarkston, Michigan (PRWEB) , ... ... ... their direction with respect to fertility once they have been diagnosed with endometriosis. ... for tolerable intercourse but they also require a comprehensive approach that can help ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
(Date:6/25/2016)... ... ... Conventional wisdom preaches the benefits of moderation, whether it’s a matter of indulgence ... high can result in disappointment, perhaps even self-loathing. However, those who set the bar ... from PsychTests.com reveals that behind the tendency to set low expectations is ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Bay Area ... Network,s Dean Center for Tick Borne Illness ... and Rehabilitation, MIT Hacking Medicine, University of California, ... today announced the five finalists of Lyme ... disease.  More than 100 scientists, clinicians, researchers, entrepreneurs, ...
(Date:6/24/2016)... 2016 Dehaier Medical Systems Ltd. (NASDAQ: ... markets and sells medical devices and wearable sleep respiratory ... strategic cooperation agreement with Hongyuan Supply Chain Management Co., ... June 20, 2016, to develop Dehaier,s new Internet medical ... Dehaier will leverage Hongyuan Supply Chain,s sales platform to ...
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
Breaking Medicine Technology: